Thus, we generated CRC-based models of ALI cultures and organoids and assessed CFTR expression and modulator response in a third genotype bearing L1077P allele, specifically the compound heterozygous L1077P/R1066C genotype, available at the CF center (Patient 4 in Table1). This evidence concerns the gene CFTR and colorectal carcinoma.